<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01476748</url>
  </required_header>
  <id_info>
    <org_study_id>2011P001825</org_study_id>
    <nct_id>NCT01476748</nct_id>
  </id_info>
  <brief_title>Intraoperative Trocar Slippage Study</brief_title>
  <official_title>A Pilot Study to Determine the Extent of Intraoperative Laparoscopic Trocar Slippage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out how much a trocar might slide during a typical
      laparoscopic hysterectomy. We also want to find out if there is a difference between how much
      three commonly used trocars slide and if a device called LaproStop has an effect on the
      slippage.

      Patients will be randomly assigned into the different trocar groups. After this assignment
      has been made, we will then assign the Laprostop to one of the two trocars by chance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trocar Slippages With LaproStop</measure>
    <time_frame>During the hysterectomy procedure, up to 2 hours and 32 minutes</time_frame>
    <description>Number of participants with slippages with LaproStop</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trocar Slippages Without LaproStop</measure>
    <time_frame>During the hysterectomy procedure, up to 2 hours and 32 minutes</time_frame>
    <description>Number of participants with slippages with LaproStop</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Trocar Slippage</condition>
  <arm_group>
    <arm_group_label>Ethicon Xcel Trocars</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ethicon Xcel trocars will be used in this arm with Laprostop device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covidien Veraport Trocars</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Covidien Veraport Trocars will be used in this arm with the Laprostop device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Storz Reusable Trocars</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Storz Reusable Trocars will be used in this arm with the Laprostop device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LaproStop</intervention_name>
    <description>One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
    <arm_group_label>Ethicon Xcel Trocars</arm_group_label>
    <arm_group_label>Covidien Veraport Trocars</arm_group_label>
    <arm_group_label>Storz Reusable Trocars</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing a hysterectomy at Brigham and Women's Hospital and Faulkner Hospital.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon I Einarsson, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minimal Invasieve Gynaecology Surgery, Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2011</study_first_submitted>
  <study_first_submitted_qc>November 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <results_first_submitted>August 23, 2013</results_first_submitted>
  <results_first_submitted_qc>August 19, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 29, 2014</results_first_posted>
  <last_update_submitted>September 8, 2014</last_update_submitted>
  <last_update_submitted_qc>September 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Jon I. Einarsson</investigator_full_name>
    <investigator_title>MD, MPH</investigator_title>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment took place in a tertiary hospital, from 12-26-12 to 06-18-13</recruitment_details>
      <pre_assignment_details>All enrolled participants were included in the trial</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Covidien Veraport Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="P2">
          <title>Ethicon Xcel Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="P3">
          <title>Storz Reusable Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Covidien Veraport Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="B2">
          <title>Ethicon Xcel Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="B3">
          <title>Storz Reusable Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="5"/>
            <count group_id="B4" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.8" spread="2.48"/>
                    <measurement group_id="B2" value="43" spread="9.61"/>
                    <measurement group_id="B3" value="44.6" spread="6.34"/>
                    <measurement group_id="B4" value="45.13" spread="6.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Trocar Slippages Without LaproStop</title>
        <description>Number of participants with slippages with LaproStop</description>
        <time_frame>During the hysterectomy procedure, up to 2 hours and 32 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Covidien Versaport Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
          <group group_id="O2">
            <title>Ethicon Xcel Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
          <group group_id="O3">
            <title>Storz Reusable Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
        </group_list>
        <measure>
          <title>Trocar Slippages Without LaproStop</title>
          <description>Number of participants with slippages with LaproStop</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="4.47"/>
                    <measurement group_id="O2" value="2" spread="2.68"/>
                    <measurement group_id="O3" value="4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Trocar Slippages With LaproStop</title>
        <description>Number of participants with slippages with LaproStop</description>
        <time_frame>During the hysterectomy procedure, up to 2 hours and 32 minutes</time_frame>
        <population>Pilot study</population>
        <group_list>
          <group group_id="O1">
            <title>Covidien Versaport Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
          <group group_id="O2">
            <title>Ethicon Xcel Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
          <group group_id="O3">
            <title>Storz Reusable Trocars</title>
            <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
          </group>
        </group_list>
        <measure>
          <title>Trocar Slippages With LaproStop</title>
          <description>Number of participants with slippages with LaproStop</description>
          <population>Pilot study</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Covidien Veraport Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="E2">
          <title>Ethicon Xcel Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
        <group group_id="E3">
          <title>Storz Reusable Trocars</title>
          <description>LaproStop : One of the subject's trocars will be randomized to be used with a LaproStop device.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There were no adverse events encountered during this study</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. JI Einarsson</name_or_title>
      <organization>BWH</organization>
      <phone>617-525-8582</phone>
      <email>jeinarsson@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

